Osimert 80 mg (Osimertinib)

Osimert 80 mg is the Bangladeshi version of osimertinib. It is formulated with the original formula. Original tagrisso and Bangladesh made Osimert work the same. Not only that, Bangladeshi Osimert costs about 70℅ less than the original Tagrisso but can deliver the same results. Osimert-80 is manufactured by Everest Pharmaceutical Limited. similar medicine is available from a different manufacturer. The name is Tagrix 80 mg 

 

FAQ About Osimert 80 mg

Q: What kind of drug is osimertinib?

Osimertinib belongs to the group of medicines called antineoplastic (cancer medicines). It works by interfering with the growth of cancer cells, which are eventually destroyed.

 

Q: Is Osimert a form of chemotherapy?

No, Osimert is not chemotherapy, but targeted therapy. Targeted therapies work differently than traditional chemotherapy. Chemotherapy kills rapidly dividing cells and can affect many types of cells in the body, including healthy cells.

 

Q: Is Osimert a targeted therapy?

(Osimert^®) is a targeted therapy drug. IDoctors use it to treat non-small cell lung cancer.

 

Q: How effective is Osimert?

Osimert 80 reduced the risk for disease recurrence or death by 79%). Osimert  associated with superior DFS rates at 1 (97% vs 69%), 2 (89% vs 53%), and 3 years (79% vs 41%). The cancer drug (Tagrisso) improves survival in people with non-small cell lung cancer with EGFR mutations,

 

Q: Who invented this drug?

AstraZeneca Pharmaceuticals developed Osimert (previously known as mereletinib or AZD9291, trade name Tagrisso), a third-generation drug for mutated EGFR cancers.

Q: What is the cost of this medicine?

In the U.S., this medicine cost $17,028.90 per month, compared erlotinib (Tarceva, Genentech) at $9,390.44, gefitinib (Iressa, AstraZeneca) at $9,117.36 and afatinib (Gilotrif, Boehringer Ingelheim) at $9,785.72. In the Bangladeshi version of Osimert Price is around $150 to $300 for 30 Tablets. before your order check our Terms & Condition

 

 

Use in Pregnancy & Lactation: Osimert can cause fetal harm when administered to a pregnant woman. There are no available data on Osimert use in pregnant women.

Lactation: There are no data on the presence of Osimert in human milk. The effects of Osimert on the breastfed infant, or milk production.

 

Overdose: If an overdose occurs, the medical team must monitor the patient for evidence of toxicity. Treatment of overdose includes monitoring of vital signs as well as observation of the clinical status of the patient.

 

Storage  Store in a cool and dry place, away from light. Keep out of the reach of children.